Tuberculosis reactivation at ileum following immune checkpoint inhibition with pembrolizumab for metastatic nasopharyngeal carcinoma: a case report

Tuberculosis reactivation at ileum following immune checkpoint inhibition with pembrolizumab for metastatic nasopharyngeal carcinoma: a case report

Abstract Background Tuberculosis (TB) reactivation has been increasingly identified following immune checkpoint inhibitor (ICI) therapy for cancer patients. However there has been no report on TB reactivation in the gastrointestinal tract. In the report, we describe a patient who developed TB ileiti...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Kin-Sang Lau, Ben Man-Fei Cheung, Ka-On Lam, Sum-Yin Chan, Ka-Ming Lam, Chun-Fai Yeung, Ivan Fan-Ngai Hung, Dora Lai-Wan Kwong, Chi-Chung Tong, To-Wai Leung, Mai-Yee Luk, Anne Wing-Mui Lee, Kwok-Keung Yuen, Victor Ho-Fun Lee
Format: article
Langue:EN
Publié: BMC 2021
Sujets:
Nasopharyngeal carcinoma
Immune checkpoint inhibitors
Tuberculosis reactivation
IGRA
Infectious and parasitic diseases
RC109-216
Accès en ligne:https://doaj.org/article/2540bea4e0744c0db3e2bb0711216fb7
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/2540bea4e0744c0db3e2bb0711216fb7

Documents similaires